In recognition of his exceptional dedication to advancing understanding of leukemia and other myeloid malignancies, Dr. Stephen Nimer, director of Sylvester Comprehensive Cancer Center in Miami, has been named "Researcher of the Year" by BioFlorida, an association for the state's life sciences industry.
Desai Sethi Urology Institute, whose leaders have been at the forefront of advancing high intensity frequency ultrasound (HIFU) as a nerve-sparing treatment for prostate cancer, performed their 150th case, a milestone rarely achieved by many.
Can exercise, intermittent fasting and other lifestyle changes help patients with advanced breast cancer better tolerate side effects from treatment? A new $4-million NCI-funded study at Sylvester Comprehensive Cancer Center seeks to answer that question.
Many physician-scientists and other researchers from Sylvester Comprehensive Cancer Center will make oral or poster presentations and participate in panel discussions at the American Society of Radiation Oncology (ASTRO) 2023 annual meeting in San Diego, Oct. 1-4.
An ASTRO 2023 panel will delve into the topic of physician burnout within radiation oncology and medicine in general.
EMBARGOED ASTRO PRESENTATION: Is it true progression or pseudoprogression in tumor growth? That’s the critical question for radiation and medical oncologists treating patients with glioblastoma. Sylvester researchers will present results from two recent studies at ASTRO 2023.
The work of principal investigator Alberto Ramos, M.D., M.S., underscores the importance of sleep studies for a group that has an elevated risk for Alzheimer’s disease.
Desai Sethi Urology Institute at the University of Miami Miller School of Medicine will host its second annual, in-person Urology on the Beach meeting, January 19 to 21, 2024, at the Fontainebleau Hotel in Miami Beach.
Isabel is fortunate. Her breast cancer was detected early, and she needed only lumpectomies for removal, three weeks of radiation and a long-term drug regimen.
A new study published online ahead of print in The Journal of Thoracic and Cardiovascular Surgery suggests that socioeconomic status is linked with outcomes and survival in patients treated for non-small cell lung cancer.
The National Institutes of Health has funded two University of Miami Miller School of Medicine faculty through its Helping to Accelerate Research Potential (HARP) UE5 grant program. The grant’s aim is to pair newly funded researchers nationwide with experienced mentors.
Glen N. Barber, PhD, Sylvester Comprehensive Cancer Center’s internationally known cell biologist who chairs the University of Miami’s Department of Cell Biology, will be awarded the 2023 Louisa Gross Horwitz Prize from Columbia for outstanding contributions to basic research in biology and biochemistry.
Thoracic surgeons and researchers at Sylvester Comprehensive Cancer Center found that increasing numbers of patients undergoing cancer-removal lung surgery by “anatomic lung resections” are able to go home safely and without complications one day after the operation.
Researchers at Sylvester Comprehensive Cancer Center found that robot-assisted surgeries and new patient-care protocols are enabling lung cancer surgery patients to go home earlier, with less pain and almost always without a need for potentially addictive opioids.
In a newly published paper in Blood, researchers from Sylvester Comprehensive Cancer Center and collaborating organizations clarify current treatment approaches in the management of patients with secondary central nervous system lymphoma (SCNSL) caused by aggressive lymphoma.
The National Institute of General Medical Sciences has awarded Justin Taylor, M.D., a researcher at Sylvester Comprehensive Cancer Center, a five-year grant totaling $1.92 million for his work to better define the role of XPO1 (Exportin-1) in cancer.
A new study from researchers with Sylvester Comprehensive Cancer Center and other top-tier cancer centers highlights the vital role that the immune system plays in determining the duration of patients’ remission from multiple myeloma.
Race and ethnicity may play a role in liver cancer, which disproportionately affects people of low socioeconomic status, as well as immigrants, veterans and incarcerated populations.
Cancer patients often face anxiety, depression and distress. Prostate cancer survivor, Julio Monsalve, enrolled in a large study at Sylvester evaluating the role that stress can play in survivors’ lives and the potential benefits of facing that stress head-on. He's now on a mission, encouraging other Latinos to get screened for cancer.
Findings from the newly published study in The Journal of Clinical Investigation suggest a large proportion of men have testosterone concentrations that are much higher in and around the prostate than traditional blood draws suggest. And this elevated exposure near the prostate increases the risk of poor outcomes after surgical removal of the prostate gland.
Researchers at Sylvester Comprehensive Cancer Center are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies. Article in Aug. 31 issue of Nature Medicine.
Sylvester Comprehensive Cancer Center's "Game Changer" teams are on a mission to address health disparities and save lives by closing critical gaps in access to cancer education, prevention and research.
Researchers with Sylvester Comprehensive Cancer Center have been awarded a three-year, $800,000 grant from the U.S. Department of Defense (DoD)’s Congressionally Directed Medical Research Program to target chemotherapy resistance in pancreatic cancer.
New research shows blood cancers are often misdiagnosed, an NCI grant to develop a urine test for prostate cancer, a surgeon-scientist receives Sylvester’s first DoD grant to study pancreatic cancer, bolstering emergency preparedness for climate-driven disasters, and more are included in this month’s tip sheet .
A study to explore a new way to noninvasively detect prostate cancer is under way at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. The $2.5 million, five-year National Cancer Institute (NCI) grant is led by Sanoj Punnen, M.D.
Blood disorders known as myelodysplastic syndromes/neoplasms are commonly misdiagnosed – putting patients at increased risk for treatment mistakes and other potentially harmful consequences. A new study highlights the vital need for strong coordination between clinicians and skilled pathologists to ensure accurate, timely diagnosis of blood cancers.
Tracy Crane, PhD, RDN, co-lead of Cancer Control at Sylvester Comprehensive Cancer Center has been appointed vice chair of NRG Oncology’s Cancer Prevention and Control Committee.
The University of Miami Miller School of Medicine Department of Otolaryngology has received a new $3.2 million, five-year grant from the National Institutes of Health (NIH) to support their multidisciplinary translational research program on human genetic hearing loss (HL), a common sensory disorder affecting more than 28 million Americans.
Sanoj Punnen, M.D., co-chair of the Genitourinary Site Disease Group at Sylvester Comprehensive Cancer Center and associate professor and vice chair of research, Desai Sethi Urology Institute, at the University of Miami Miller School of Medicine, is leading a $2.5 million, five-year National Cancer Institute (NCI) grant to explore a new way to noninvasively detect prostate cancer.
Researchers with Sylvester Comprehensive Cancer Center and collaborating organizations will study how new technology can help cancer patients manage symptoms and related stress from cancer treatment while at home.
A first-of-its kind drug for prostate cancer, an ancient retrovirus that may drive aggressive brain cancer, disparities in endometrial cancer rates among Black women, a new trial seeking answers for higher rates of aggressive prostate and breast cancer in Black men and women, and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Cancer centers are uniquely positioned to protect cancer patients from climate-driven disasters, but researchers identified significant shortcomings in emergency preparedness when it came to climate-related disasters.
Researchers from Sylvester Comprehensive Cancer Center and Dana Farber Cancer Institute have been awarded $7 million in total funding to study how diet and exercise impact mental and physical functioning in older cancer survivors and their caregivers.
Dylan Thompson is used to feeling out of place. In high school, he was one of the only Black students in his advanced classes. When he started at the University of Miami, he again found himself as one of the only Black students in his pre-med classes. Relief came for him, though, in the form of the Diversity in Cancer Research Internship Program at Sylvester Comprehensive Cancer Center.
Researchers at Sylvester Comprehensive Cancer Center have developed a first-of-its-kind, orally administered drug to disrupt prostate cancer cells’ metabolism and deliver the chemotherapy agent cisplatin directly into treatment-resistant prostate cancer cells. The compound – Platin-L – works in two ways, breaking down a process that malignant prostate cancer cells use to fuel their growth, and delivering cisplatin directly into treatment-resistant cancer cells.
Cancer Disparities: A new African Cancer Genome Registry at Sylvester Comprehensive Cancer Center in Miami seeks to find reasons for higher prostate and breast cancer rates in people of African ancestry. Dr. Sophia George, co-principal investigator, is available for interviews, as are two breast and prostate cancer study participants.
A new, EMBARGOED study suggests that reactivation of an ancient retrovirus from 6 million years ago may be at least partly to blame for the aggressiveness and treatment resistance of some glioblastomas.
A new study led by two neurologists at the University of Miami Miller School of Medicine points to a potential novel form of Car T cellular therapy for myasthenia gravis (MG), a chronic autoimmune disorder characterized by muscle weakness. The study findings were recently published in the British journal Lancet Neurology.
Cancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency department (ED) visits and hospitalizations, according to new research from Sylvester Comprehensive Cancer Center.
A new EMBARGOED study found that endometrial cancer rates in Black women are related to factors beyond ancestry, including social determinants of health such as diet, psychosocial and physiological chronic stress and neighborhood/built environmental factors.
A world-renowned biochemist joins the Sylvester Cancer team, a global health leader strives to ensure more equitable cancer care, a recent study identifies disparities in federal cancer research funding, new targeted therapies for thyroid and other cancers are making surgery a secondary option for many patients, efforts to preserve women’s sexual health while they receive endocrine therapy for breast cancer, and more are highlighted in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Danny Reinberg, Ph.D., one of the world’s foremost biochemists, is joining Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, bringing decades of ground-breaking research in genetics, epigenetics and cellular processes.
An interventional radiologist and a urologist with UHealth – University of Miami Health System and the Miller School of Medicine highlighted an innovative procedure to treat enlarged prostate glands at a June 5 Capitol Hill briefing on men’s health.
A research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine compiled and analyzed statistics from federal cancer research funding sources and found that funds tend to be allocated more heavily toward cancers that occur more often in non-Hispanic white people than in other racial and ethnic groups.
In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.
Historically, surgery was the first line of treatment for patients with thyroid cancer. Now, as targeted therapies and other new medications emerge, surgery for certain patients may become more of a secondary option if those treatments fail. This new context could potentially change how some procedures are conducted.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
